Therapeutic effect of peripheral administration of an anti-prion protein antibody on mice infected with prions

Microbiology and Immunology

Volumn 57, Issue 4, 2013, Pages 288-297

  Ohsawa, Natsuo ^a   Song, Chang Hyun ^a,c   Suzuki, Akio ^a   Furuoka, Hidefumi ^b   Hasebe, Rie ^a   Horiuchi, Motohiro ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

^b OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^c Daegu Haany University   (South Korea)

Author keywords

Blood brain barrier; Immunotherapy; Prion; Scrapie

Indexed keywords

ISOPROTEIN; MONOCLONAL ANTIBODY 31C6; PRION PROTEIN; PRION PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG EFFECT; DRUG MECHANISM; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRION DISEASE; RIGHT HEMISPHERE; THALAMUS; WEIGHT REDUCTION;

ADMINISTRATION, INTRAVENOUS; ANIMALS; ANTIBODIES, MONOCLONAL; BRAIN; FEMALE; IMMUNOTHERAPY; MICE; PRION DISEASES; PROTEIN ISOFORMS; PRPSC PROTEINS;

MUS;

EID: 84876432381     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12037     Document Type: Article

References (33)

1. Trevitt C.R., Collinge J. (2006) A systematic review of prion therapeutics in experimental models. Brain 129: 2241-65.
2. Enari M., Flechsig E., Weissmann C. (2001) Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc Natl Acad Sci USA 98: 9295-9.
3. Feraudet C., Morel N., Simon S., Volland H., Frobert Y., Creminon C., Vilette D., Lehmann S., Grassi J. (2005) Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem 280(11): 247-58.
4. Gilch S., Wopfner F., Renner-Muller I., Kremmer E., Bauer C., Wolf E., Brem G., Groschup M.H., Schatzl H.M. (2003) Polyclonal anti-PrP auto-antibodies induced with dimeric PrP interfere efficiently with PrPSc propagation in prion-infected cells. J Biol Chem 278(18): 524-31.
5. Kim C.L., Karino A., Ishiguro N., Shinagawa M., Sato M., Horiuchi M. (2004) Cell-surface retention of PrPC by anti-PrP antibody prevents protease-resistant PrP formation. J Gen Virol 85: 3473-82.
6. Peretz D., Williamson R.A., Kaneko K., Vergara J., Leclerc E., Schmitt-Ulms G., Mehlhorn I.R., Legname G., Wormald M.R., Rudd P.M., Dwek R.A., Burton D.R., Prusiner S.B. (2001) Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412: 739-43.
7. Perrier V., Solassol J., Crozet C., Frobert Y., Mourton-Gilles C., Grassi J., Lehmann S. (2004) Anti-PrP antibodies block PrPSc replication in prion-infected cell cultures by accelerating PrPC degradation. J Neurochem 89: 454-63.
8. White A.R., Enever P., Tayebi M., Mushens R., Linehan J., Brandner S., Anstee D., Collinge J., Hawke S. (2003) Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422: 80-3.
9. Fernandez-Borges N., Brun A., Whitton J.L., Parra B., Diaz-San Segundo F., Salguero F.J., Torres J.M., Rodriguez F., (2006) DNA vaccination can break immunological tolerance to PrP in wild-type mice and attenuates prion disease after intracerebral challenge. J Virol 80: 9970-6.
10. Goni F., Knudsen E., Schreiber F., Scholtzova H., Pankiewicz J., Carp R., Meeker H.C., Rubenstein R., Brown D.R., Sy M.S., Chabalgoity J.A., Sigurdsson E.M., Wisniewski T. (2005) Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience 133: 413-21.
11. Schwarz A., Kratke O., Burwinkel M., Riemer C., Schultz J., Henklein P., Bamme T., Baier M. (2003) Immunisation with a synthetic prion protein-derived peptide prolongs survival times of mice orally exposed to the scrapie agent. Neurosci Lett 350: 187-9.
12. Sigurdsson E.M., Brown D.R., Daniels M., Kascsak R.J., Kascsak R., Carp R., Meeker H.C., Frangione B., Wisniewski T. (2002) Immunization delays the onset of prion disease in mice. Am J Pathol 161: 13-7.
13. Song C.H., Furuoka H., Kim C.L., Ogino M., Suzuki A., Hasebe R., Horiuchi M. (2008) Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice. J Gen Virol 89: 1533-44.
14. Genoud N., Ott D., Braun N., Prinz M., Schwarz P., Suter U., Trono D., Aguzzi A. (2008) Antiprion prophylaxis by gene transfer of a soluble prion antagonist. Am J Pathol 172: 1287-96.
15. Wuertzer C.A., Sullivan M.A., Qiu X., Federoff H.J. (2008) CNS delivery of vectored prion-specific single-chain antibodies delays disease onset. Mol Ther 16: 481-6.
16. Kim C.L., Umetani A., Matsui T., Ishiguro N., Shinagawa M., Horiuchi M. (2004) Antigenic characterization of an abnormal isoform of prion protein using a new diverse panel of monoclonal antibodies. Virology 320: 40-51.
17. Horiuchi M., Mochizuki M., Ishiguro N., Nagasawa H., Shinagawa M. (1997) Epitope mapping of a monoclonal antibody specific to feline panleukopenia virus and mink enteritis virus. J Vet Med Sci 59: 133-6.
18. Horiuchi M., Yamazaki N., Ikeda T., Ishiguro N., Shinagawa M. (1995) A cellular form of prion protein (PrPC) exists in many non-neuronal tissues of sheep. J Gen Virol 76 (Pt 10): 2583-7.
19. Nakamitsu S., Kurokawa A., Yamasaki T., Uryu M., Hasebe R., Horiuchi M. (2010) Cell density-dependent increase in the level of protease-resistant prion protein in prion-infected Neuro2a mouse neuroblastoma cells. J Gen Virol 91: 563-9.
20. Vorbrodt A.W., Dobrogowska D.H., Tarnawski M., Meeker H.C., Carp R.I. (1997) Immunocytochemical evaluation of blood-brain barrier to endogenous albumin in scrapie-infected mice. Acta Neuropathol 93: 341-8.
21. Brandner S., Isenmann S., Kuhne G., Aguzzi A. (1998) Identification of the end stage of scrapie using infected neural grafts. Brain Pathol 8: 19-27.
22. Chung Y.L., Williams A., Beech J.S., Williams S.C., Bell J.D., Cox I.J., Hope J. (1995) MRI assessment of the blood-brain barrier in a hamster model of scrapie. Neurodegeneration 4: 203-7.
23. Wisniewski H.M., Madrid R.E. (1983) Chronic progressive experimental allergic encephalomyelitis (EAE) in adult guinea pigs. J Neuropathol Exp Neurol 42: 243-55.
24. Priller J., Prinz M., Heikenwalder M., Zeller N., Schwarz P., Heppner F.L., Aguzzi A. (2006) Early and rapid engraftment of bone marrow-derived microglia in scrapie. J Neurosci 26(11): 753-62.
25. Phares T.W., Kean R.B., Mikheeva T., Hooper D.C. (2006) Regional differences in blood-brain barrier permeability changes and inflammation in the apathogenic clearance of virus from the central nervous system. J Immunol 176: 7666-75.
26. Ermolayev V., Cathomen T., Merk J., Friedrich M., Hartig W., Harms G.S., Klein M.A., Flechsig E. (2009) Impaired axonal transport in motor neurons correlates with clinical prion disease. PLoS Pathog 5: e1000558.
27. Bencsik A., Philippe S., Debeer S., Crozet C., Calavas D., Baron T. (2007) Scrapie strain transmission studies in ovine PrP transgenic mice reveal dissimilar susceptibility. Histochem Cell Biol 127: 531-9.
28. Paxinos G., Franklin K.B.J. (2001) The Mouse Brain in Stereotaxic Coordinates, 2nd edn. San Diego: Academic Press.
29. Alexandrenne C., Wijkhuisen A., Dkhissi F., Hanoux V., Creminon C., Boquet D., Couraud J.Y. (2009) Generating antibodies against the native form of the human prion protein (hPrP) in wild-type animals: a comparison between DNA and protein immunizations. J Immunol Methods 341: 41-9.
30. Campana V., Zentilin L., Mirabile I., Kranjc A., Casanova P., Giacca M., Prusiner S.B., Legname G., Zurzolo C. (2009) Development of antibody fragments for immunotherapy of prion diseases. Biochem J 418: 507-15.
31. Donofrio G., Heppner F.L., Polymenidou M., Musahl C., Aguzzi A. (2005) Paracrine inhibition of prion propagation by anti-PrP single-chain Fv miniantibodies. J Virol 79: 8330-8.
32. Borchelt D.R., Taraboulos A., Prusiner S.B. (1992) Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem 267(16): 188-99.
33. Caughey B., Raymond G.J. (1991) The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem 266(18): 217-23.